Anthony Bergmann insider trades: Capricor Therapeutics (CAPR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Anthony reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | CAPR | ↓ Sell | 24,100 | $30.38 | $732K | Direct | Jun 29, 2026 (4d) |
| Jun 24, 2026 | CAPR | ↓ Sell | 900 | $30.00 | $27K | Direct | Jun 24, 2026 (0d) |
| Mar 31, 2026 | CAPR | ↓ Sell | 25,000 | $30.13 | $753K | Direct | Apr 1, 2026 (1d) |
| Mar 16, 2016 | CAPR | ↑ Buy | 2,030 | $2.40 | $5K | Direct | Mar 18, 2016 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CAPR insiders
Open-market trades in the last 12 months
About Anthony Bergmann's insider trades
Anthony Bergmann is Chief Financial Officer at Capricor Therapeutics (CAPR). Since Mar 16, 2016, Anthony has reported 1 open-market purchase worth $5K and 3 sales worth $1.5M on SEC Form 4. In the last 12 months: 3 sales ($1.5M).
Their filings also include grants and awards (13 filings), option exercises (6 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CAPR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.